Navigation Links
Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017
Date:7/7/2011

ucation as to healthy lifestyle needs to be initiated much earlier in life. Perhaps the definition of intelligence could be transformed to mean those who know best how to care for themselves in a healthy manner.

US Medicare CMS defines telehealth as remote health care delivery via monitoring. A healthcare provider can connect more consistently with patients. Telehealth: phone monitoring is the implementation of scheduled encounters via the telephone. Telemonitoring relates to the collection and transmission of vital signs clinical data through electronic information processing technologies. Quality improvement organizations (QIOs) assist home health agencies in implementing telehealth tools to reduce acute care hospitalization.

According to Susan Eustis, the principal author of the study, "The advantage of telemonitoring is that it increases patient compliance. The aim is to improve the delivery of healthcare to clients by monitoring vital signs to detect changes in patient condition that may indicate the onset of a more serious event, much as nurses in the hospital monitor patient vital signs for the purpose of permitting sophisticated care delivery."

The aim of telemonitoring is to improve patient compliance with standards of care known to support improved outcomes for patients with chronic conditions. Tele-monitoring is one way to improve patient compliance, but there are other ways to achieve that as well.

Chronic condition care requires daily, real-time monitoring of physiological data, direct patient feedback, coaching, and a high level of patient-clinician interaction to achieve positive results. With the geographical distance widening between doctors and their patients, the problem solution depends on: digital literacy and effective multimodal communication.

Home patient monitoring means two things: the imminent rise of the expert patient whom the health authorities anticipate would self-manage his long-term medical conditi
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Orange and Medic4all Launched the Worlds First Cellular Tele-Health Service
2. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
3. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
4. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
5. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
6. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
7. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
8. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
9. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
10. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
11. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 The maker community is ... of inventions. They focus on learning practical skills while ... gravitate toward bringing their ideas to life via crowdfunding. ... works on making projects using biology. Glowing Plant has ... to make them glow with bioluminescence genes, and has ...
(Date:5/23/2013)... MARINO, Calif. , May 23, 2013 /PRNewswire/ ... today a strategic alliance with DAK Renewable Research ... the corn oil yield. VG Energy is a ... (OTC Pink: VGLS). VG Energy,s exclusively ... to increase the oil yield in plants, possessing ...
(Date:5/23/2013)... 2013 Virobay, Inc. today announced that their ... an important milestone, as Virobay has now initiated a ... cathepsin S inhibitor.   The first Phase ... study designed to evaluate the safety, tolerability, pharmacokinetics and ... "The initiation of this Phase 1 trial ...
(Date:5/23/2013)... On April 19th the Center for Disease ... the growing antibiotic resistant bacteria that may be lurking ... study were released late last month showing higher antibiotic ... years. For those suffering from bacteria driven acne, Probiotic ... in food, may eventually help breed acne causing bacteria. ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2
... Warrant Amount by an Additional ... $44.5 million, ... that a single institutional investor,has agreed to purchase, for $44.5 million, newly ... per share, and a,warrant to purchase approximately 28.2 million shares of common ...
... eResearchTechnology,Inc. (eRT or the Company), (Nasdaq: ERES ... technology, ePRO and other services to the,pharmaceutical, biotechnology, ... of Mr. Keith D. Schneck as Executive Vice,President ... Mr. Schneck joins eRT with over 30 ...
... Plans for Regaining Compliance - - NASDAQ Hearing Panel ... ... Other NASDAQ Capital Market Initial Listing ... TUSTIN, Calif., July 23 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ...
Cached Biology Technology:Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 3eResearchTechnology Names New Chief Financial Officer 2eResearchTechnology Names New Chief Financial Officer 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 2Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 4
(Date:5/23/2013)... MADISON, Wis. In an age when microbial pathogens ... to tamp down infection, a team of Wisconsin scientists ... of curbing the bacteria that cause staph infections. , ... Chemical Society , a group led by University of ... interfere with the "quorum sensing" behavior of Staphylococcus ...
(Date:5/22/2013)... Screening Trial (NLST) investigators also conclude that the ... low-dose computed tomography (LDCT) versus chest X-ray (CXR) ... is achievable at experienced screening centers in the ... to share with their patients about the benefits ... today,s publication in the New England Journal ...
(Date:5/22/2013)... developed a novel technique that can detect molecular variants ... is one of the most important, though time-consuming, processes ... paper in Nature , post-doctoral researcher David Patterson, ... of the Center for Free-Electron Laser Science (CFEL) in ... microwave fields to identify molecular variants apart, and to ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Detecting mirror molecules 2Detecting mirror molecules 3
... D.C. A class of Alzheimer,s disease drugs currently ... by traumatic brain injury in animals, researchers at Georgetown ... publication of Nature Medicine . They say ... potentially do something no other drug has been able ...
... 15, 2009 Researchers at Memorial Sloan-Kettering Cancer Center ... tendency to develop some blood disorders may be inherited. ... , identifies a common genetic sequence abnormality that enhances ... linked to certain blood diseases. The investigators carried ...
... National Institute of Environmental Health Sciences (NIEHS), part of ... major presence at the annual Society of Toxicology (SOT) ... the National Toxicology Program (NTP), which NIEHS administers, as ... newest advances, applications and thinking in the field of ...
Cached Biology News:Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 2Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 3Hear about emerging trends in toxicology research 2
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
Human Xg Affinity Purified Polyclonal Ab Keywords: Xg glycoprotein, hereditary hemorrhagic telangiectasia Protein Family: ...
Vitellogenin (Japanese medaka) Standard...
Mouse Collagen IV...
Biology Products: